YueShan

    • YueShanYueShan
      ·00:45
      Good ⭐⭐⭐

      AI芯片設計公司的全球化佈局策略

      @金星匯MoneyLeadersClub
      生成式人工智能的快速演進,正把AI芯片從一個高度專業化的半導體分支,推向全球科技競爭的戰略核心。算力不再只是性能指標,而成為國家產業政策、企業商業模式與地緣供應鏈博弈的交匯點。在這樣的背景下,來自矽谷、深圳與歐洲的AI芯片設計公司,走出了三條看似分歧、實則互補的全球化路徑,而這些差異,正在為2026年的產業佈局埋下伏筆。 美國AI芯片公司的設計思路,始終圍繞「平臺」二字展開。無論是雲端訓練還是推理加速,其核心目標都是打造一種高度通用、可被軟件生態不斷放大的算力底座。這類芯片在架構上追求極高的可編程性,容許不同模型、框架與算法快速迭代,即便在能效與成本上並非最優,仍能憑藉生態優勢建立長期護城河。 中國,尤其是深圳一帶的AI芯片設計公司,則更傾向於「場景先行」。在智慧城市、工業視覺、車載系統與邊緣計算等應用中,客戶更關心的是即時性、能耗與整體方案成本,而非通用性。這使得中國企業在設計時,往往針對特定算法與負載進行深度優化,形成「專用算力」的競爭優勢。這種思路不一定在全球話語權上佔先,但在落地效率與商業化速度上更具現實意義。 歐洲企業的設計邏輯則顯得剋制而工程化。其AI芯片多服務於汽車、工業控制與關鍵基礎設施,對安全性、可靠性與法規合規有極高要求。算力不是唯一追求,長期穩定運行與系統整合能力纔是核心,這也使歐洲AI芯片在性能競賽中保持低調,卻在高門檻市場中站穩腳跟。 客戶結構差異 設計思路的不同,直接塑造了三地企業截然不同的客戶結構。美國AI芯片公司高度依賴少數超大型平臺型客戶,雲服務商與科技巨頭既是最大買家,也是技術路線的重要塑造者。這種結構帶來的是「贏者通吃」的擴張效應,但同時也意味著收入高度集中、供應鏈議價博弈激烈。 中國企業的客戶結構則更為分散。大量來自不同行業的中大型客戶,推動芯片快速迭代與定製化發展。雖然單一訂單規模有限,但風險分散,且更容易複製到新興市場。這種模式讓
      AI芯片設計公司的全球化佈局策略
      0Comment
      Report
    • YueShanYueShan
      ·12-31 00:20
      Good ⭐⭐⭐
      @Muppy
      $Microsoft(MSFT)$ [Tongue] [Tongue] [Tongue] [Grin] [Grin] [Grin] [Grin] [Glance] [Glance] [Glance] [Glance] [Glance] [Glance] [Glance] [Glance] [Glance] [Glance] [Glance] [Glance] [Glance] [Glance] [Glance] [Grin]
      $Microsoft(MSFT)$ [Tongue] [Tongue] [Tongue] [Grin] [Grin] [Grin] [Grin] [Glance] [Glance] [Glance] [Glance] [Glance] [Glance] [Glance] [Glance] [Glance] [Glance] [Glance] [Glance] [Glance] [Glance] [Glance] [Grin]
      68Comment
      Report
    • YueShanYueShan
      ·2025-12-26
      Good ⭐⭐⭐
      9Comment
      Report
    • YueShanYueShan
      ·2025-12-21
      Good ⭐⭐⭐
      172Comment
      Report
    • YueShanYueShan
      ·2025-12-20
      Good ⭐⭐⭐
      362Comment
      Report
    • YueShanYueShan
      ·2025-12-10
      Good ⭐⭐⭐
      @红运2022
      $Strategy(MSTR)$ 哥們,你該上去了
      $Strategy(MSTR)$ 哥們,你該上去了
      359Comment
      Report
    • YueShanYueShan
      ·2025-12-10
      Good ⭐⭐⭐
      360Comment
      Report
    • YueShanYueShan
      ·2025-12-08
      Good ⭐⭐⭐
      @ARKK Investment Tracker
      ARKK Investment Tracker position change: Increased position in Pacific Biosciences of California by 121,704 shares, the number of shares held increased 0.58% compared to the previous period and now represents 0.71% of the total position.
      ARKK Investment Tracker position change: Increased position in Pacific Biosciences of California by 121,704 shares, the number of shares held increased 0.58% compared to the previous period and now represents 0.71% of the total position.
      550Comment
      Report
    • YueShanYueShan
      ·2025-12-07
      Good ⭐⭐⭐
      896Comment
      Report
    • YueShanYueShan
      ·2025-12-03
      Good ⭐⭐⭐

      MSTR Holds Long-Term Support, MU Overheated, AMD Waiting for Dip

      @PeterDiCarlo
      1. $Strategy(MSTR)$ MSTR is sitting on key long‑term support. ⚠️Monthly bias + volume profile are at a historically strong level, but I’m waiting for the Monthly BX to turn up before going long. Last time this combo hit, MSTR rallied +1,234% in ~2 years.If I really wanted exposure here, I’d be selling cash‑secured puts around $120–$140. 2. $Micron Technology(MU)$ I’m not starting a new MU position ANYTIME soon It’s up 154% since our Monthly BX trigger 6 months ago, and while the model still prices a best case of $350 by 2027, short‑term it’s overheated and R:R isn’t ideal.If I were already in, I’d hold. To start fresh, I’d want a ~25% pullback. 3. $Advanced Micro Device
      MSTR Holds Long-Term Support, MU Overheated, AMD Waiting for Dip
      401Comment
      Report
       
       
       
       

      Most Discussed